Upcoming System Maintenance

Notice:Promega will be performing essential system updates January 21–25.

Order processing and shipping will pause starting January 21 at 4:00 PM CST and resume on January 26.
Please plan to order in advance for any products needed during this timeframe.

Please contact Customer Service with any questions.
Phone: (608) 274-4330
Toll-Free Phone: (800) 356-9526
Email: custserv@promega.com
Hours: 8am-5pm CST, Monday-Friday

Citations Search

Sort By:

Infect. Immun. 71, 3971–8. Development of DNA vaccines against hemolytic-uremic syndrome in a murine model. 2003

Capozzo, A.V.E., Creydt, V.P., Dran, G., Fernández, G., Gómez, S., Bentancor, L.V., Rubel, C., Ibarra, C., Isturiz, M. and Palermo, M.S.

Notes: Researchers used the pGEM®-T Vector System to clone the entire 1.4kb Shiga toxin type 2 gene (Stx2) from E. coli O157-H7 C600 (933W). The resultant construct, named pGEMTStx2, was used as a template in PCR to amplify each region of the gene corresponding to Shiga toxin type 2 subunits A and B. Each PCR product was digested with BamHI and EcoRI before ligation into pCDNA 3.1+ (Invitrogen) to create pStx2ΔA and pStx2B. Mice were then immunized with either one or both of these constructs and another construct expressing murine granulocyte-macrophage colony-stimulating factor. Expression of each subunit in mouse tissue was verified by RT-PCR with specific primers and the AccessQuick™ RT-PCR System. (2701)

Expand Full Notes »